Thymic carcinoma MRI

Thymic Carcinoma Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thymic carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Thymic carcinoma MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Google Images
American Roentgen Ray Society Images of Thymic carcinoma MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thymic carcinoma MRI
CDC on Thymic carcinoma MRI
Thymic carcinoma MRI in the news
Blogs on Thymic carcinoma MRI
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Thymic carcinoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]Parminder Dhingra, M.D. [3]

MRI

• T1: isointense to slightly hyperintense signal compared to muscle
• T2:heterogeneous signal, slightly higher than muscle

cystic areas may be seen, especially in larger tumours fibrous septa crossing the mass are of low signal intensity in/out phase imaging: typically no signal drop out i.e. no chemical shift

• T1 C+ (Gd): linear regions of enhancement may be seen coursing though the mass, thought to represent fibrous septae